Neville BW et al (2016) Oral and maxillofacial pathology, vol xiii, 4th edn. Elsevier, St. Louis, p 912
Czerniak B, Dorfman HD (2016) Dorfman and Czerniak’s bone tumors, vol xiii, 2nd edn. Elsevier, Philadelphia, p 1506
Hameed M, Horvai AE, Jordan RCK (2020) Soft tissue special issue. Head Neck Pathol 14:70–82
Article PubMed PubMed Central Google Scholar
Lee RJ et al (2015) Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study. JAMA Otolaryngol Head Neck Surg 141(5):470–477
Liang L et al (2019) An individual patient data meta-analysis on the effect of chemotherapy on survival in patients with craniofacial osteosarcoma. Head Neck 41(6):2016–2023
Bousquet M et al (2016) Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations. Ann Oncol 27(4):738–744
Article CAS PubMed Google Scholar
Chen X et al (2014) Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep 7(1):104–112
Article CAS PubMed PubMed Central Google Scholar
Kovac M et al (2015) Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency. Nat Commun 6:8940
Article CAS PubMed Google Scholar
Suehara Y et al (2019) Clinical genomic sequencing of pediatric and adult osteosarcoma reveals distinct molecular subsets with potentially targetable alterations. Clin Cancer Res 25(21):6346–6356
Article CAS PubMed PubMed Central Google Scholar
Behjati S et al (2017) Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. Nat Commun 8:15936
Article CAS PubMed PubMed Central Google Scholar
Cheng DT et al (2015) Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn 17(3):251–264
Article CAS PubMed PubMed Central Google Scholar
Zehir A et al (2017) Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med 23(6):703–713
Article CAS PubMed PubMed Central Google Scholar
Board WCOTE (2020) Soft Tissue and Bone Tumours: WHO Classification of Tumours. International Agency for Research on Cancer
Korbel JO, Campbell PJ (2013) Criteria for inference of chromothripsis in cancer genomes. Cell 152(6):1226–1236
Article CAS PubMed Google Scholar
Stephens PJ et al (2011) Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144(1):27–40
Article CAS PubMed PubMed Central Google Scholar
Zhang CZ et al (2015) Chromothripsis from DNA damage in micronuclei. Nature 522(7555):179–184
Article CAS PubMed PubMed Central Google Scholar
Schumacher TN, Schreiber RD (2015) Neoantigens in cancer immunotherapy. Science 348(6230):69–74
Article CAS PubMed Google Scholar
Strachan T, Read AP (2019) Human molecular genetics, vol xiii, 5th edn. CRC Press, Taylor & Francis Group, Boca Raton, p 770
Cortes-Ciriano I et al (2020) Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat Genet 52(3):331–341
Article CAS PubMed PubMed Central Google Scholar
Perry JA et al (2014) Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proc Natl Acad Sci U S A 111(51):E5564–E5573
Article CAS PubMed PubMed Central Google Scholar
Tawbi HA et al (2017) Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol 18(11):1493–1501
Article CAS PubMed PubMed Central Google Scholar
Ruggieri P et al (1994) Malignancies in fibrous dysplasia. Cancer 73(5):1411–1424
Article CAS PubMed Google Scholar
Qu N et al (2015) Malignant transformation in monostotic fibrous dysplasia: clinical features, imaging features, outcomes in 10 patients, and review. Medicine (Baltimore) 94(3):e369
Tanner HC Jr, Dahlin DC, Childs DS Jr (1961) Sarcoma complicating fibrous dysplasia. Probable role of radiation therapy. Oral Surg Oral Med Oral Pathol 14:837–46
Shi R et al (2022) Clinicopathological and genetic study of a rare occurrence: malignant transformation of fibrous dysplasia of the jaws. Mol Genet Genomic Med 10(1):e1861
Article CAS PubMed PubMed Central Google Scholar
Yap FHX et al (2021) Malignant transformation of fibrous dysplasia into osteosarcoma confirmed with TP53 somatic mutation and mutational analysis of GNAS gene. Pathology 53(5):652–654
Article CAS PubMed Google Scholar
Lee SE et al (2012) The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases. Hum Pathol 43(8):1234–1242
Article CAS PubMed Google Scholar
Jour G et al (2016) GNAS mutations in fibrous dysplasia: a comparative study of standard sequencing and locked nucleic acid PCR sequencing on decalcified and nondecalcified formalin-fixed paraffin-embedded tissues. Appl Immunohistochem Mol Morphol 24(9):660–667
Article CAS PubMed PubMed Central Google Scholar
Lyons J et al (1990) Two G protein oncogenes in human endocrine tumors. Science 249(4969):655–659
Article CAS PubMed Google Scholar
Kuznetsov SA et al (2008) Age-dependent demise of GNAS-mutated skeletal stem cells and “normalization” of fibrous dysplasia of bone. J Bone Miner Res 23(11):1731–1740
留言 (0)